GLP-1 Injectable Tirzepatide

Tirzepatide Starter

A clinician-guided weekly injection program built on compounded Tirzepatide, the active ingredient in Mounjaro® and Zepbound®, with dual GIP/GLP-1 receptor activity. Includes provider consultation, ongoing oversight, supplies, and shipping. Personalized dose titration based on your response.

12-Week ProgramTirzepatide
Titration 2.5–7.5 mg
Due today
$299$224
CareCreditCareCredit
AffirmAffirm
KlarnaKlarna
AfterpayAfterpay
Book Now

Prescription only. Price includes clinician review, medication and supplies. Discount applies to your first order.

Personalized Dose Titration

Dose adjusted based on tolerance and clinical response, not a fixed protocol.

Clinician-Supervised Program

Board-certified licensed providers oversee treatment, monitor response, and adjust as needed.

Weekly Self-Administration

Single subcutaneous injection per week, taught via secure video walkthrough.

Supplies Included

Syringes, alcohol pads, and sharps disposal information shipped with each refill.

Discreet Home Delivery

Medication ships directly to your door from a U.S.-licensed compounding pharmacy.

All treatment plans require medical evaluation and approval. Individual results may vary.

Need Branded Medications?

Get access to trusted, branded weight loss medications like Zepbound and Wegovy - delivered to your door in ease-to-use pen injectors.

Request Now

Take control of your health in 4 simple, affordable steps

Personalized Intake

1

Tell us about your health, goals, and history through a secure intake questionnaire.

Clinician Review

2

A licensed clinician reviews your information and determine what's right for you

Medication Delivered

3

Your prescribed medication is prepared by a partner pharmacy and shipped to your home.

Ongoing support

4

Your progress is monitored with follow-ups and dose refinements as needed.

Understanding GLP-1 Injections

Learn how compounded GLP-1 medications work, who they're for, and what to expect.

Designed for Safety. Guided by Clinicians.

  • All patients complete a medical intake before any prescription decision
  • Treatment plans are reviewed and approved by board-certified licensed providers
  • Dose titration is conservative and based on individual response
  • Ongoing follow-ups support safety and tolerability

GLP-1 therapy is not suitable for individuals with certain medical conditions, including personal or family history of medullary thyroid carcinoma or MEN 2. A clinician will determine eligibility during consultation.

Woman smiling confidently after starting her weight management journey

Serving all 50 States with science-first, outcome-driven wellness.

We're proud to support a global community of people committed to feeling better and living sharper — no matter where they are.

Our patients trust us because we combine real medicine with real care.

4.8

Frequently Asked Questions

Get answers to commonly asked questions.

Yes. GLP-1 medications are prescription-only. After your intake, a licensed clinician determines whether treatment is appropriate based on your history and clinical findings.

Medication ships directly from a U.S.-licensed compounding pharmacy in temperature-controlled packaging. Refrigerate upon arrival and follow the storage instructions provided with your prescription.

Most patients experience gradual changes over the first several weeks of treatment. Because the program emphasizes safe titration, changes vary by individual.

The most commonly reported side effects are mild gastrointestinal symptoms — nausea, constipation, or fatigue — typically during dose increases. Side effects are reviewed at every follow-up.

In many cases, yes. Compatibility is determined by your clinician based on your medical history and current medications.

Still have questions? Contact us

Reach your goal weight with care that fits your life.

A short medical questionnaire is all we need. A licensed provider reviews your answers, writes your prescription if you qualify, and ships it to your door.

Reviewed and prescribed by U.S.-licensed providers